We presented our experience at AMEE 2023
AMEE 2023 took place from 26-30 August 2023 at the Scottish Event Campus (SEC), Glasgow, UK. We are pleased to present our experience at the…
AMEE 2023 took place from 26-30 August 2023 at the Scottish Event Campus (SEC), Glasgow, UK. We are pleased to present our experience at the…
We are thrilled to announce that our Simulation Training Platform “ClinCaseQuest” has been featured on HealthySimulation.com, the world’s premier Healthcare Simulation resource website. We are…
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies (Anthracycline Chemotherapy) from the Cardio-Oncology Study Group of the Heart Failure Association…
The National Institutes of Health Stroke Scale (NIHSS) is a scale designed to assess the neurological status of a stroke patient. The scale assesses level of…
We are at SESAM 2023 with oral presentation “Stage Debriefing in Simulation Training in Medical Education for Competencies Formation”. ClinCaseQuest team had a great opportunity…
Charlson Comorbidity Index predicts 10-year survival in patients with multiple comorbidities. Variable Points Age <50 years 0 50–59 years +1 60–69 years +2 70–79…
For Multiple Myeloma Diagnostic Criteria assessment necessary to provide selection of the appropriate criteria: Criteria (A) Clonal bone marrow plasma cells ≥10% or (B) biopsy-proven…
Revised Multiple Myeloma International Staging System (R-ISS) – prognostication tool for myeloma patients based on the genetics and other routinely used lab values in conjunction…
Multiple Myeloma International Staging System (ISS) prognosticates the severity of multiple myeloma based on routinely obtained lab values. Use only in patients recently diagnosed with…
SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulators. Variable Points Surgery within 90 days +2 Mongoloid race -3 History…